Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glymur
- Development stage
- Preclinical
- Lead developer
- Academic Centre for Dentistry in Amsterdam
- Administration
- Topical
01
Overview
**Glymur** is an investigational oral-rinse formulation evaluated for **halitosis**. A randomized placebo-controlled study assessed 14 days of use in volunteers, measuring changes in oral-microbiota composition, total microbial proteolytic activity, and oral malodor. Publicly available study information does not disclose the rinse's active ingredients or a defined molecular target; its intended effect appears to be modulation of oral microbial activity associated with production of malodor-causing volatile sulfur compounds.
- Other names
- GlymurGlymur oral rinseGlymur rinse
Beyond the preview
Go deeper on Glymur.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glymur.